Dr. Laszlo Radvanyi, OICR’s President and Scientific Director, answers a question about precision medicine and discusses how OICR is working to improve access to this form of cancer treatment through the development of liquid biopsies.
Ask a Cancer Researcher: How does a tumour’s genetics factor into cancer care?
